Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

8.470 -1.440 (-14.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94,895
Open 9.810
Bid (Size) 8.600 (4)
Ask (Size) 8.800 (1)
Prev. Close 9.910
Today's Range 8.450 - 9.827
52wk Range 3.722 - 11.78
Shares Outstanding 6,356,270
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
Via Investor Brand Network
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Performance

YTD
+86.1%
+86.1%
1 Month
+10.0%
+10.0%
3 Month
+66.4%
+66.4%
6 Month
+74.3%
+74.3%
1 Year
+41.6%
+41.6%

More News

Read More
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Declares 25% Preferred Stock Dividend Linked to AVERSA Fentanyl Approval
Via Investor Brand Network
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
From Nutriband Inc.
Via GlobeNewswire
Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy (NTRB, COLL, ASRT, AQST)
Via AB Newswire
Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy
Via News Direct
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
Via Investor Brand Network
Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Price Target Raised to $15 Following AVERSA Fentanyl Manufacturing Milestone
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
Via Investor Brand Network
Topics Death Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Aversa Fentanyl with Kindeva to Commercial Manufacturing Scale
Via Investor Brand Network
Topics Intellectual Property
NUTRIBAND AND KINDEVA COMPLETE COMMERCIAL MANUFACTURING PROCESS SCALE-UP FOR AVERSA™ FENTANYL ABUSE DETERRENT FENTANYL PATCH
Via FinancialNewsMedia
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
Via FinancialNewsMedia
Topics Death
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030
From FN Media Group LLC
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Reports Double-Digit Revenue Increase, Continued Progress on AVERSA Fentanyl Development
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology
Via Investor Brand Network
Topics Intellectual Property
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
Nutriband Inc. (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value
Via Investor Brand Network
Topics Initial Public Offering
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference
Via Investor Brand Network
Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development
Via Investor Brand Network
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast
Via Investor Brand Network

Frequently Asked Questions

Is Nutriband Inc. - Common Stock publicly traded?
Yes, Nutriband Inc. - Common Stock is publicly traded.
What exchange does Nutriband Inc. - Common Stock trade on?
Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Common Stock?
The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Common Stock?
The current price of Nutriband Inc. - Common Stock is 8.470
When was Nutriband Inc. - Common Stock last traded?
The last trade of Nutriband Inc. - Common Stock was at 07/07/25 04:00 PM ET
What is the market capitalization of Nutriband Inc. - Common Stock?
The market capitalization of Nutriband Inc. - Common Stock is 53.84M
How many shares of Nutriband Inc. - Common Stock are outstanding?
Nutriband Inc. - Common Stock has 54M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.